Document is current
Any future updates will be listed below
-
Authors
Connolly, John B. https://orcid.org/0000-0002-7033-3463
Mumford, John D. https://orcid.org/0000-0001-8964-1784
Fuchs, Silke https://orcid.org/0000-0001-8921-7422
Turner, Geoff
Beech, Camilla
North, Ace R. https://orcid.org/0000-0002-4253-396X
Burt, Austin https://orcid.org/0000-0001-5146-9640
-
Funding
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV006610)
Open Philanthropy Project Fund (O-77157)
- License Information
-
More Information
Article History
Received: 13 November 2020
Revised: 24 February 2021
Accepted: 25 February 2021
First Online: 29 March 2021
Declaration
:
: Not applicable.
: Not applicable.
: JBC: Employment by Imperial College London in a position which is solely funded through a grant from the Bill & Melinda Gates Foundation, Member of Target Malaria not-for-profit research consortium; Travel grants from FNIH. JDM: Employment by Imperial College London; Member of Target Malaria not-for-profit research consortium; Research grants from Bill & Melinda Gates Foundation; Working Group and Hearing Expert for European Food Safety Authority; Travel grants from FNIH, World Health Organisation and International Atomic Energy Agency. SF: Employment by Imperial College London in a position which is solely funded through a grant from the Bill & Melinda Gates Foundation; Member of Target Malaria not-for-profit research consortium; Travel grants from FNIH. GT: Employment by Imperial College London in a position which is solely funded through a grant from the Bill & Melinda Gates Foundation, and was formerly funded solely through a grant from the Open Philanthropy Project Fund, an advised fund of Silicon Valley Community Foundation; Member of Target Malaria not-for-profit research consortium; Travel grants from FNIH; Former employee of Oxitec Ltd, an entity with commercial interests in genetic insect technologies. CB: Paid consultancy with Imperial College London, a partner in the Target Malaria non-for-profit research consortium; Former employee at Oxitec Ltd., an entity with commercial interests in genetic insect technologies, and shareholder in its parent company Intrexon Inc.; Member of the World Health Organisation Vector Control Advisory Group; Member of the International Society for Biosafety Research (ISBR); Member of ISBR program committee for 2019 conference, receiving an honorarium for attendance at the conference; Travel grants from FNIH. ARN: Employment by University of Oxford in a position which is solely funded through a grant from the Bill & Melinda Gates Foundation; Member of Target Malaria not-for-profit research consortium; Travel grants from FNIH. AB: Employment by Imperial College London; Principle Investigator of the Target Malaria not-for-profit research consortium, which receives core funding from the Bill & Melinda Gates Foundation and from the Open Philanthropy Project Fund, an advised fund of Silicon Valley Community Foundation.
